Masculinization of the female fetus associated with norethindrone-mestranol therapy during pregnancy.
D000014:Abnormalities, Drug-Induced; D000033:Abortion, Threatened / Q000517:prevention & control; D000328:Adult; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008656:Mestranol / Q000009:adverse effects*; D009640:Norethindrone / Q000009:adverse effects*; D011247:Pregnancy; D014770:Virilism / Q000139:chemically induced*
D003277:Contraceptives, Oral, Combined; D008656:Mestranol; D009640:Norethindrone